Two-Year Cumulative and Functional Patency after Creation of Endovascular Arteriovenous Hemodialysis Fistulae

J Vasc Interv Radiol. 2024 Jun;35(6):846-851.e2. doi: 10.1016/j.jvir.2024.02.012. Epub 2024 Feb 19.

Abstract

Purpose: To assess 2-year cumulative and functional patency of endovascular arteriovenous fistulae (endoAVF) created with the WavelinQ device.

Materials and methods: Patients who had fistulae created at a single center from December 2019 to December 2020 were included in this retrospective study. Forty-three patients underwent endoAVF creation (22 females, 21 males). Data collected included patient demographics, location of fistula creation, interventions performed, and brachial artery flow before and after creation. Two-year cumulative and functional patency rates were assessed with Kaplan-Meier method, and variables that affected patency and maturation were examined using Cox proportional hazards model.

Results: Technical success was 95% (41/43), and in 4 patients, the fistula did not mature for dialysis use (9.7%). For the remaining 37 patients with endoAVF maturation, 25 had ulnar-ulnar fistulae, 10 had radial-radial fistulae, and 2 had interosseous artery-vein fistulae. Mean maturity time was 73 days, and brachial artery flow of >886 mL/min was predictive of maturation. Mean tunneled dialysis catheter removal time was 133 days. Number of interventions per patient-year was 0.38, where 8 were maturation procedures (5 vein elevations/transpositions and 3 coil embolizations) and 21 were maintenance angioplasties. Two-year cumulative/secondary and functional patency rates were 89.4% and 92.1%, respectively, with a mean follow-up of 665.7 days. Examined variables did not impact cumulative or functional patency. One adverse event was migration of coil to the heart, which was successfully retrieved at time of procedure.

Conclusions: Two-year patency of 89.4% and functional patency of 92.1% were observed after endoAVF creation with WavelinQ device.

MeSH terms

  • Adult
  • Aged
  • Arteriovenous Shunt, Surgical* / adverse effects
  • Blood Flow Velocity
  • Brachial Artery / physiopathology
  • Brachial Artery / surgery
  • Endovascular Procedures* / adverse effects
  • Endovascular Procedures* / instrumentation
  • Female
  • Graft Occlusion, Vascular* / etiology
  • Graft Occlusion, Vascular* / physiopathology
  • Graft Occlusion, Vascular* / therapy
  • Humans
  • Male
  • Middle Aged
  • Renal Dialysis*
  • Retrospective Studies
  • Risk Factors
  • Time Factors
  • Treatment Outcome
  • Upper Extremity / blood supply
  • Vascular Patency*